Sokhom S Pin Selected Research

Sokhom S Pin Research Topics

4	Migraine Disorders (Migraine) 01/2021 - 08/2008
2	Neuroblastoma 06/2008 - 12/2007
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/2021
1	Parkinson Disease (Parkinson's Disease) 01/2021
1	Major Depressive Disorder (Major Depressive Disorders) 11/2018

3	Calcitonin Gene-Related Peptide Receptors (Calcitonin-Gene Related Peptide Receptor)IBA 01/2021 - 12/2007
3	Calcitonin Gene-Related PeptideIBA 01/2021 - 08/2008
3	Calcitonin Gene-Related Peptide Receptor AntagonistsIBA 01/2021 - 04/2012
2	4- (8- fluoro- 2- oxo- 1,2- dihydroquinazolin- 3(4H)- yl)- N- (3- (7- methyl- 1H- indazol- 5- yl)- 1- oxo- 1- (4- (piperidin- 1- yl)piperidin- 1- yl)propan- 2- yl)piperidine- 1- carboxamideIBA 04/2012 - 08/2008
2	Adenylyl Cyclases (Adenylyl Cyclase)IBA 06/2008 - 12/2007
1	Adrenergic Antagonists (Antiadrenergic Agents)IBA 01/2021
1	EnzymesIBA 01/2021
1	Tamsulosin (Flomax)FDA LinkGeneric 01/2021
1	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2021
1	Terazosin (Hytrin)FDA LinkGeneric 01/2021
1	alfuzosin (UroXatral)FDA Link 01/2021
1	Doxazosin (Cardura)FDA LinkGeneric 01/2021
1	Adenosine Triphosphate (ATP)IBA 01/2021
1	Buprenorphine (Subutex)FDA LinkGeneric 11/2018
1	ALKS 5461IBA 11/2018
1	3-carboxamido-4-hydroxynaltrexoneIBA 11/2018
1	Tryptamines (Triptans)IBA 06/2013
1	N- (3- (7- methyl- 1H- indazol- 5- yl)- 1- (4- (1- methylpiperidin- 4- yl)- 1- oxopropan- 2- yl))- 4- (2- oxo- 1,2- dihydroquinolin- 3- yl)piperidine- 1- carboxamideIBA 06/2013
1	piperidineIBA 06/2013
1	AmidesIBA 04/2012
1	pyridineIBA 04/2012

2	Therapeutics 01/2021 - 06/2013